Mutation and haplotype analyses of the MUT gene in Japanese patients with methylmalonic acidemia

被引:27
|
作者
Sakamoto, Osamu
Ohura, Toshihiro
Matsubara, Yoichi
Takayanagi, Masaki
Tsuchiya, Shigeru
机构
[1] Tohoku Univ, Sch Med, Dept Pediat, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 980, Japan
[3] Chiba Childrens Hosp, Chiba, Japan
关键词
methylmalonic academia; L-methylmalonyl-CoA mutase;
D O I
10.1007/s10038-006-0077-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Methylmalonic acidemia (MMA) is caused by a deficiency in the activity of L-methylmalonyl-CoA mutase (MCM), a vitamin B12 (or cobalamin, Cbl)-dependent enzyme. Apoenzyme-deficient MMA (mut MMA) results from mutations in the nuclear gene MUT. Most of the MUT mutations are thought to be private or restricted to only a few pedigrees. Our group elucidated the spectrum of mutations of Japanese mut MMA patients by performing mutation and haplotype analyses in 29 patients with mut MMA. A sequence analysis identified mutations in 95% (55/58) of the disease alleles. Five mutations were relatively frequent (p.E117X, c.385 + 5G > A, p.R369H, p.L494X, and p.R727X) and four were novel (p.M1V, c.753_753 + 5delGGTATA, c.1560G > C, and c.2098_2099delAT). Haplotype analysis suggested that all of the frequent mutations, with the exception of p.R369H, were spread by the founder effect. Among 46 Japanese patients investigated in the present and previous studies, 76% (70/92) of the mutations were located in exons 2, 6, 8, and 13. This finding - that a limited number of mutations account for most of the mutations in Japanese mut MMA patients - is in contrast with results of a previous study in Caucasian patients.
引用
收藏
页码:48 / 55
页数:8
相关论文
共 50 条
  • [41] Clinical presentation, molecular analysis and follow-up of patients with mut methylmalonic acidemia in Shandong province, China
    Han, Bingjuan
    Nie, Wenying
    Sun, Meng
    Liu, Yingxia
    Cao, Zhiyang
    PEDIATRICS AND NEONATOLOGY, 2020, 61 (02): : 148 - 154
  • [42] Clinical outcomes of patients with mut-type methylmalonic acidemia identified through expanded newborn screening in China
    Ling, Shiying
    Wu, Shengnan
    Shuai, Ruixue
    Yu, Yue
    Qiu, Wenjuan
    Wei, Haiyan
    Yang, Chiju
    Xu, Peng
    Zou, Hui
    Feng, Jizhen
    Niu, Tingting
    Hu, Haili
    Zhang, Huiwen
    Liang, Lili
    Wang, Yu
    Chen, Ting
    Xu, Feng
    Gu, Xuefan
    Han, Lianshu
    HUMAN GENOMICS, 2024, 18 (01)
  • [43] A MURINE MODEL OF MUT (0) METHYLMALONIC ACIDEMIA (MMA) TREATED BY ORTHOTOPIC LIVER TRANSPLANTATION
    Manoli, I.
    Chandler, R. J.
    Zerfas, P.
    Hoffmann, V.
    Venditti, C. P.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 121 - 122
  • [44] MOLECULAR AND STRUCTURAL ANALYSIS OF SIX NONSENSE MUTATIONS IN MUT METHYLMALONIC ACIDEMIA PATIENTS INCLUDING TWO NOVEL NONSENSE MUTATIONS
    Dundar, H.
    Ozgul, R. K.
    Unal, O.
    Karaca, M.
    Aydin, H., I
    Tokatli, A.
    Sivri, H. S.
    Coskun, T.
    Dursun, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S177 - S177
  • [45] MaP NATURAL HISTORY STUDY: CLINICAL AND BIOMARKER FINDINGS IN METHYLMALONIC ACIDEMIA DUE TO MUT DEFICIENCY
    Schiff, Manuel
    Schwahn, Bernd C.
    Chabrol, Brigitte
    Merritt, J. Lawrence, II
    Vockley, Jerry
    Vernon, Hilary
    Berry, Gerard T.
    Santra, Saikat
    Lee, Chung
    Koeberl, Dwight
    Li, Hong
    Burton, Barbara
    De las Heras, Javier
    Diaz, George
    Faria-Urbina, Mariana
    Luo, Junxiang
    Attarwala, Husain
    Sikirica, Vanja
    Liang, Min
    Guey, Lin T.
    Lukacs, Christine
    Martini, Paolo G. V.
    Glaser, Ruchira
    Carrillo, Nuria
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (03) : 84 - 84
  • [46] Treatment of Methylmalonic Acidemia by Targeted Integration of MUT into Albumin Using an Optimized Promoterless AAV Vector
    Venturoni, Leah E.
    Chandler, Randy J.
    Chau, Nelson
    Liao, Jing
    Kay, Mark A.
    Barzel, Adi
    Venditti, Charles P.
    MOLECULAR THERAPY, 2019, 27 (04) : 367 - 367
  • [47] Mutation screening and haplotype analysis of the rhodopsin gene locus in Japanese patients with retinitis pigmentosa
    Ando, Yuichiro
    Ohmori, Masayuki
    Ohtake, Hideki
    Ohtoko, Kuniyo
    Toyama, Shigeru
    Usami, Ron
    O'hira, Aya
    Hata, Hiromi
    Yanashima, Kenji
    Kato, Seishi
    MOLECULAR VISION, 2007, 13 (113-15): : 1038 - 1044
  • [48] A Compound Heterozygote Mutation in a Chinese Patient Affected with Methylmalonic Acidemia
    Yang, Yu
    Huang, Hui
    Yuan, Yi
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 340 - 340
  • [49] Tricarboxylic Acid Cycle Enzymes in Patients with Methylmalonic Acidemia and Propionic Acidemia
    Wongkittichote, Parith
    Cunningham, Gary
    Pumbo, Elena
    Lee, Fiona
    Summar, Marshall L.
    Chapman, Kimberly A.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (03) : 277 - 277
  • [50] Gene Therapy for Methylmalonic Acidemia: Past, Present, and Future
    Chandler, Randy J.
    Venditti, Charles P.
    HUMAN GENE THERAPY, 2019, 30 (10) : 1236 - 1244